サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1347691

ハイコンテントスクリーニング市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

High Content Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ハイコンテントスクリーニング市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のハイコンテントスクリーニング市場規模は2022年に12億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に8.4%の成長率（CAGR）を示し、市場は2028年までに20億米ドルに達すると予測しています。

ハイコンテントスクリーニング（HCS）は、ハイコンテンツ解析（HCA）としても知られ、細胞の表現型と生物学的逸脱を特定する自動顕微鏡法です。薬剤候補が疾患の経過を変化させるかどうかを判断し、細胞の形態や表現型を変化させるペプチドやRNAiなどの微小分子を同定するのに役立ちます。マルチカラー蛍光イメージングの自動記録とハイスループット定量データ解析を組み合わせた、創薬におけるセルベーススクリーニングの高度なアプローチです。これにより、専門家は複数のエピジェネティック・マークに対する化合物の活性をスクリーニングし、評価することができます。その結果、HCSは製薬会社やバイオテクノロジー企業、学術機関、政府機関、受託研究機関（CROS）などで広く利用されています。

アルツハイマー病やパーキンソン病などの慢性疾患や神経変性疾患の有病率の増加は、世界中のHCSの需要にプラスの影響を与えている主な要因の一つです。さらに、このような病気にかかりやすい高齢化人口の増加が、市場の成長に寄与しています。これとは別に、大手企業は、スクリーニングシステムの視覚化機能を向上させるために、ソフトウェアプラットフォームや人工知能（AI）システムと統合された革新的なHCS機器を導入しています。また、細胞分離やスケーラビリティを分析するための自動化システムが開発され、HCS技術の採用がさらに進んだことも一因と考えられます。さらに、手頃な価格の創薬システムに対するニーズが高まっていることから、製薬業界にも広く応用されています。これに加えて、多くの国の行政機関が先進的なスクリーニングシステムの研究開発（R&D）にかなりの投資を行っており、ヘルスケアインフラの大幅な改善とともに、市場の見通しを明るいものにしています。

本レポートで扱う主な質問

  • ハイコンテントスクリーニングの世界市場はこれまでどのように推移してきたのか？
  • 主要な地域市場は？
  • COVID-19が世界のハイコンテントスクリーニング市場に与えた影響は？
  • 製品別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のハイコンテントスクリーニング市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ハイコンテントスクリーニングの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 器械
    • 市場動向
    • 主要タイプ
      • 細胞イメージング・解析システム
      • フローサイトメーター
    • 市場予測
  • 消耗品
    • 市場動向
    • 主な種類
      • 試薬＆測定キット
      • マイクロプレート
      • その他
    • 市場予測
  • ソフトウェア
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測
  • 付属品
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • ターゲットの特定と検証
    • 市場動向
    • 市場予測
  • 一次スクリーニングと二次スクリーニング
    • 市場動向
    • 市場予測
  • 毒性試験
    • 市場動向
    • 市場予測
  • 化合物プロファイリング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • 学術・政府機関
    • 市場動向
    • 市場予測
  • CRO（医薬品開発業務受託機関）
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Biotek Instruments Inc.
    • Danaher Corporation
    • GE Healthcare
    • Merck Millipore
    • Perkinelmer Inc.
    • Tecan Group Ltd.
    • Thermo Fisher Scientific
    • Yokogawa Electric Corporation
図表

List of Figures

  • Figure 1: Global: High Content Screening Market: Major Drivers and Challenges
  • Figure 2: Global: High Content Screening Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: High Content Screening Market: Breakup by Product (in %), 2022
  • Figure 4: Global: High Content Screening Market: Breakup by Application (in %), 2022
  • Figure 5: Global: High Content Screening Market: Breakup by End-User (in %), 2022
  • Figure 6: Global: High Content Screening Market: Breakup by Region (in %), 2022
  • Figure 7: Global: High Content Screening Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: High Content Screening (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: High Content Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: High Content Screening (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: High Content Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: High Content Screening (Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: High Content Screening (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: High Content Screening (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: High Content Screening (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: High Content Screening (Accessories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: High Content Screening (Accessories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: High Content Screening (Target Identification and Validation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: High Content Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: High Content Screening (Primary Screening and Secondary Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: High Content Screening (Primary Screening and Secondary Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: High Content Screening (Toxicity Studies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: High Content Screening (Toxicity Studies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: High Content Screening (Compound Profiling) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: High Content Screening (Compound Profiling) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: High Content Screening (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: High Content Screening (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: High Content Screening (Academic and Government Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: High Content Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: High Content Screening (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: High Content Screening (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: North America: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: North America: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: United States: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: United States: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Canada: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Canada: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Asia Pacific: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Asia Pacific: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: China: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: China: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Japan: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Japan: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: India: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: India: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: South Korea: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: South Korea: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Australia: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Australia: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Indonesia: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Indonesia: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Others: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Europe: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Europe: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Germany: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Germany: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: France: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: France: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: United Kingdom: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: United Kingdom: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Italy: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Italy: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Spain: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Spain: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Russia: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Russia: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Latin America: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Latin America: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Brazil: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Brazil: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Mexico: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Mexico: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Others: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Middle East and Africa: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Middle East and Africa: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: High Content Screening Industry: SWOT Analysis
  • Figure 83: Global: High Content Screening Industry: Value Chain Analysis
  • Figure 84: Global: High Content Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: High Content Screening Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: High Content Screening Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: High Content Screening Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: High Content Screening Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 5: Global: High Content Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: High Content Screening Market: Competitive Structure
  • Table 7: Global: High Content Screening Market: Key Players
目次
Product Code: SR112023A1988

Market Overview:

The global high content screening market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.

High content screening (HCS), also known as high-content analysis (HCA), is an automated microscopy method of identifying cellular phenotype and biological deviations. It assists in determining whether a drug candidate modifies the disease course and identifying micro-molecules such as peptides or RNAi that alter the cell morphology and phenotype. It is an advanced approach to cell-based screening in drug discovery, which combines the automated recording of multicolor fluorescence imaging and high-throughput quantitative data analysis. It allows professionals to screen and evaluate the activity of compounds on multiple epigenetic marks. As a result, HCS is widely used in pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROS).

The increasing prevalence of chronic disorders and neurodegenerative diseases, such as Alzheimer's and Parkinson's, represents one of the major factors positively influencing the demand for HCS around the world. In addition, the rising aging population, which is more prone to such ailments, is contributing to the market growth. Apart from this, leading players are introducing innovative HCS equipment that is integrated with software platforms and artificial intelligence (AI) systems to improve the visualization capabilities of the screening systems. It can also be attributed to the development of automated systems for analyzing cell separation and scalability, which has further improved the adoption of HCS technology. Furthermore, they find extensive application in the pharmaceutical industry due to the escalating need for an affordable drug discovery system. Besides this, governing agencies of numerous countries are considerably investing in the research and development (R&D) of advanced screening systems, along with significant improvement in the healthcare infrastructure, which is creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global high content screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end-user.

Breakup by Product:

Instruments

Cell Imaging and Analysis Systems

Flow Cytometers

Consumables

Reagents & Assay Kits

Microplates

Other Consumables

Software

Services

Accessories

Instruments dominate the market due to advances in instrumentation and automation techniques with advanced visualization capability and enhanced software platforms.

Breakup by Application:

Target Identification and Validation

Primary Screening and Secondary Screening

Toxicity Studies

Compound Profiling

Other Applications

Primary screening and secondary screening currently dominates the market as primary screening helps in determining the microorganisms and organic acid in cells, whereas secondary screening assists in obtaining the quantitative and qualitative information about the cells, desired organisms or strains.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies

Academic and Government Institutes

Contract Research Organizations (CROs)

High content screening (HCS) is widely utilized in pharmaceutical and biotechnology companies for various clinical and preclinical studies.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America holds the majority of the global high content screening share due to the increasing drug discovery research in the region.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific and Yokogawa Electric Corporation.

Key Questions Answered in This Report:

  • How has the global high content screening market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global high content screening market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global high content screening market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global High Content Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Cell Imaging and Analysis Systems
      • 6.1.2.2 Flow Cytometers
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Reagents & Assay Kits
      • 6.2.2.2 Microplates
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Accessories
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Target Identification and Validation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Primary Screening and Secondary Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxicity Studies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Compound Profiling
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic and Government Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Becton, Dickinson and Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotek Instruments Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GE Healthcare
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck Millipore
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Perkinelmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Tecan Group Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Thermo Fisher Scientific
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Yokogawa Electric Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis